60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela]
RxNorm concept 2110513, branded drug (sbd). Prescribable name: Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations.
- RxCUI
- 2110513
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2110513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations
Related concepts
- salmeterol 0.05 MG/ACTUAT (SCDC, consists of)
- fluticasone propionate 0.25 MG/ACTUAT (SCDC, consists of)
- fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT [Wixela] (SBDC, consists of)
- Dry Powder Inhaler (DF, has dose form)
- Wixela (BN, has ingredient)
- 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2110513 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2110513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2110513. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.